The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.
Title | The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia. |
Publication Type | Journal Article |
Year of Publication | 2009 |
Authors | Tsourdi, E., Kourtis A., Farmakiotis D., Katsikis I., Salmas M., & Panidis D. |
Journal | Fertil Steril |
Volume | 91 |
Issue | 4 Suppl |
Pagination | 1427-30 |
Date Published | 2009 Apr |
ISSN | 1556-5653 |
Keywords | Adult, Dose-Response Relationship, Drug, Follicle Stimulating Hormone, Humans, Hypothalamo-Hypophyseal System, Luteinizing Hormone, Male, Middle Aged, Oligospermia, Raloxifene, Selective Estrogen Receptor Modulators, Sperm Count, Sperm Motility, Tamoxifen, Testis, Testosterone, Toremifene |
Abstract | This study evaluates, compares, and contrasts the effects of three selective estrogen receptor modulators (SERMs), namely, tamoxifen, toremifene, and raloxifene, on the hypothalamic-pituitary-testicular axis in 284 consecutive subfertile men with idiopathic oligozoospermia using three therapeutic protocols: [1] tamoxifen, 20 mg, once daily (n = 94); [2] toremifene, 60 mg, once daily (n = 99); and [3] raloxifene, 60 mg, once daily (n = 91). The antiestrogenic effects of SERMs at the hypothalamic level result in a statistically significant increase of gonadotropin levels, which is more marked for tamoxifen and toremifene compared with raloxifene. |
DOI | 10.1016/j.fertnstert.2008.06.002 |
Alternate Journal | Fertil. Steril. |
PubMed ID | 18692782 |